1. Home
  2. WB vs NUVB Comparison

WB vs NUVB Comparison

Compare WB & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weibo Corporation

WB

Weibo Corporation

N/A

Current Price

$6.37

Market Cap

1.7B

Sector

Technology

ML Signal

N/A

Logo Nuvation Bio Inc.

NUVB

Nuvation Bio Inc.

N/A

Current Price

$5.57

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WB
NUVB
Founded
2009
2018
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.1B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
WB
NUVB
Price
$6.37
$5.57
Analyst Decision
Buy
Buy
Analyst Count
17
10
Target Price
$8.24
★ $13.10
AVG Volume (30 Days)
883.9K
★ 4.0M
Earning Date
11-17-2026
11-02-2026
Dividend Yield
★ 9.44%
N/A
EPS Growth
N/A
★ 71.56
EPS
★ N/A
N/A
Revenue
N/A
★ $62,902,000.00
Revenue This Year
$0.11
$212.89
Revenue Next Year
$0.78
$41.68
P/E Ratio
$5.66
★ N/A
Revenue Growth
N/A
★ 698.96
52 Week Low
$6.37
$3.36
52 Week High
$12.77
$9.75

Technical Indicators

Market Signals
Indicator
WB
NUVB
Relative Strength Index (RSI) 32.11 36.84
Support Level N/A $5.28
Resistance Level $6.79 $5.77
Average True Range (ATR) 0.10 0.24
MACD 0.02 -0.04
Stochastic Oscillator 25.00 14.87

Price Performance

Historical Comparison
WB
NUVB

About WB Weibo Corporation

Weibo Corp is a China-based company that operates a social media platform for people to create, discover and distribute content. The company currently operates and manages its business in two principal business lines globally - advertising and marketing services and value-added services. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The company's main product is the social platform Weibo. It generates a substantial majority of its revenues from online advertising and marketing services.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Share on Social Networks: